Could an antidepressant boost brain tumor treatment?

NCT ID NCT05634707

First seen Nov 01, 2025 · Last updated May 12, 2026 · Updated 20 times

Summary

This study tests whether fluoxetine, an FDA-approved antidepressant, can make chemotherapy more effective for people with a recurrent type of brain tumor called IDHwt glioma. Ten participants will receive either fluoxetine or no additional drug before surgery, and researchers will measure changes in tumor cells. The goal is to see if fluoxetine can stress the tumor cells' lysosomes, potentially improving how well the chemotherapy drug temozolomide kills them.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRAIN TUMOR, RECURRENT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • NYU Langone Health

    New York, New York, 10016, United States

  • Stanford Cancer Institute

    Stanford, California, 94305, United States

  • The Preston Robert Tisch Brain Tumor Center at Duke University

    Durham, North Carolina, 27710, United States

  • UC San Diego Moores Cancer Center

    San Diego, California, 90074-1539, United States

Conditions

Explore the condition pages connected to this study.